Fagron NV Total Liabilities
Fagron NV total liabilities. Based on the latest financial reports, Fagron NV (FAGR) has total liabilities worth €925.69 Million EUR (≈ $1.08 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check FAGR asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Fagron NV (2004–2025)
Total liabilities of Fagron NV from 2004 to 2025. This chart illustrates how Fagron NV's total liabilities have evolved over time, based on quarterly financial data. Explore Fagron NV strategic investment ratio to see how much of total assets are deployed in long-term investments.
Fagron NV Competitors by Total Liabilities
The table below lists competitors of Fagron NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Friedrich Vorwerk Group SE
F:VH2
|
Germany | €210.59 Million |
|
Wangfujing
SHG:600859
|
China | CN¥19.44 Billion |
|
Telkom
JSE:TKG
|
South Africa | ZAC28.53 Billion |
|
Alkane Resources Ltd
AU:ALK
|
Australia | AU$382.43 Million |
|
Airport City Ltd
TA:ARPT
|
Israel | ILA8.99 Billion |
|
Yankershop Food Co Ltd
SHE:002847
|
China | CN¥2.10 Billion |
|
GPS Participações e Empreendimentos S.A
SA:GGPS3
|
Brazil | R$11.73 Billion |
|
eClerx Services Limited
NSE:ECLERX
|
India | Rs11.33 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Fagron NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Fagron NV.
Liquidity & Leverage Metrics
Fagron NV Total Liabilities Ratios Explained
Fagron NV total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fagron NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fagron NV (2004–2025)
The table below shows the annual total liabilities of Fagron NV from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €686.87 Million ≈ $803.03 Million |
+18.80% |
| 2024-12-31 | €578.16 Million ≈ $675.93 Million |
+7.20% |
| 2023-12-31 | €539.33 Million ≈ $630.53 Million |
-4.10% |
| 2022-12-31 | €562.38 Million ≈ $657.48 Million |
+18.41% |
| 2021-12-31 | €474.95 Million ≈ $555.27 Million |
-4.05% |
| 2020-12-31 | €495.01 Million ≈ $578.72 Million |
-10.78% |
| 2019-12-31 | €554.80 Million ≈ $648.62 Million |
+17.28% |
| 2018-12-31 | €473.06 Million ≈ $553.05 Million |
+15.61% |
| 2017-12-31 | €409.17 Million ≈ $478.36 Million |
-42.79% |
| 2016-12-31 | €715.18 Million ≈ $836.12 Million |
-5.17% |
| 2015-12-31 | €754.15 Million ≈ $881.69 Million |
-7.67% |
| 2014-12-31 | €816.81 Million ≈ $954.94 Million |
+25.75% |
| 2013-12-31 | €649.53 Million ≈ $759.36 Million |
+29.00% |
| 2012-12-31 | €503.51 Million ≈ $588.66 Million |
+9.51% |
| 2011-12-31 | €459.78 Million ≈ $537.53 Million |
+25.81% |
| 2010-12-31 | €365.47 Million ≈ $427.27 Million |
+32.51% |
| 2009-12-31 | €275.81 Million ≈ $322.45 Million |
+18.78% |
| 2008-12-31 | €232.20 Million ≈ $271.47 Million |
+37.20% |
| 2007-12-31 | €169.24 Million ≈ $197.86 Million |
-11.19% |
| 2006-12-31 | €190.58 Million ≈ $222.80 Million |
+0.74% |
| 2005-12-31 | €189.17 Million ≈ $221.16 Million |
+10.85% |
| 2004-12-31 | €170.65 Million ≈ $199.51 Million |
-- |
About Fagron NV
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Com… Read more